Re:Novo Nordisk's Canadian Mistake
by foxglacier on Monday October 20, 2025 @01:30AM
(#45640367)
Don't be so quick to assume it was a failure not intentional. One of the comments in the article suggests it could have been to avoid PMPRB which is price control for patented drugs.
[ Parent
| on HN ]
Re:Novo Nordisk's Canadian Mistake
by PerryUlysses on Monday October 20, 2025 @06:14AM
(#45642186)
The company said it was intentional, probably because of the reason you mentioned: “In a statement to Fortune, Novo Nordisk said there was no mistake regarding its patent maintenance fee in Canada.”
Re:Novo Nordisk's Canadian Mistake
by Scoundreller on Monday October 20, 2025 @10:44AM
(#45644498)
I still don’t get that though: is that worth losing exclusivity over?
I guess they think some other production patent will let them maintain exclusivity without it being a patent on the drug itself?